Comparison of Present Findings with Previous Findings on 131I Effect on H. pylori Eradication
| Hp-positive patients before 131I therapy (n) | 131I therapy dose (GBq) | Hp-negative patients after 131I therapy (n) | Test used to evaluate Hp infection | Reference |
|---|---|---|---|---|
| 14 with HT or PTC | 0.15–5.5 | 1 | SAT | Present study |
| 71 with DTC | 3.7–7.4 | 23 | UBT | (11) |
| 42 with DTC | NA | 5 | UBT | (14) |
| 18 with DTC | 3.7–7.4 | 0 | SAT | (17) |
Hp = H. pylori; HT = hyperthyroidism; PTC = papillary thyroid carcinoma; SAT = stool antigen test; UBT = urea breath test; NA = not applicable.